MedPage | May 15, 2017
Eric Lindblom of Georgetown University’s O’Neill Institute for National and Global Health Law said the FDA should create a fast-track regulatory review which would allow both small and large manufacturers of e-cigarettes to keep their products on the market and allow them to make reduced-risk claims if they agree to certain conditions.
He noted that in spite of the fact that e-cigarettes have been largely unregulated and that vaping is often allowed in areas where smoking is not, most smokers are not switching to e-cigarettes.
“One missing ingredient is that there hasn’t been the opportunity to make reduced harm claims and make those directly to smokers in accurate and persuasive ways,” he said.